Health Care

Viewpoints

Filter by:

The False Claims Act is Not a License to Divulge Employer Confidences

October 3, 2013 | Blog | By Brian Dunphy

Health care employers concerned that former employees may misappropriate the company’s confidential information to support qui tam lawsuits under the False Claims Act (“FCA”) received guidance from a recent court decision. 
Read more

Bipartisan Agreement Reached on Legislation Granting FDA Greater Authority to Regulate Drug Compounders

October 1, 2013 | Blog | By Roy Albert

Last week, Democrat and Republican leaders of both houses of Congress agreed to the terms of a bill that would give the U.S. Food and Drug Administration (FDA) greater authority to regulate drug compounding and would revamp the way drugs are tracked from the manufacturer to the pharmacy. 
Read more

Want to Turn on Your Employer? There’s an App for That.

September 26, 2013 | Blog | By Karen Lovitch

Plaintiffs’ firms looking to capitalize on the growth in whistleblower litigation are turning to smart phone technology to try to gain a competitive edge. Well known Delaware plaintiffs’ class action law firm Grant & Eisenhofer is attempting to enlarge its footprint in the burgeoning qui tam litigation field with a new smart phone app called, “Whistleblower Laws.
Read more

Hearing to Address HIPAA Accounting of Disclosures

September 25, 2013 | Blog | By Kimberly Gold

The HHS Office of Civil Rights (OCR) announced that the Health Information Technology (HIT) Policy Committee's Privacy and Security Tiger Team will hold a virtual, public hearing on Monday, September 30 from 11:45 a.m. to 5:00 p.m. EDT to discuss approaches for providing patients with greater transparency about the uses and disclosures of their electronic protected health information (PHI).
Read more

FDA Issues Final Mobile Medical App Guidance

September 24, 2013 | Blog | By Kimberly Gold

The U.S. Food and Drug Administration (FDA) has issued long-awaited final guidance for developers of mobile medical apps. The final guidance comes more than two years after the FDA published its draft guidance in July 2011. 
Read more

Will Usual and Customary Price be the Next False Claims Act Battleground?

September 23, 2013 | Blog | By Theresa Carnegie

Recently, a federal judge held that a qui tam relator’s allegations that a pharmacy routinely reported falsely inflated “usual and customary” prices for generic medications in claims submitted to federally funded health care programs, was sufficient to state a cause of action under the federal and certain state false claims acts.
Read more

OCR Clarifies Scope of HIPAA Prescription Refill Reminder Exception

September 20, 2013 | Blog | By Theresa Carnegie

In response to recent litigation as well as concerns from the health care industry and privacy advocates, the Office for Civil Rights (OCR) has published guidance regarding the scope of the refill reminder exception under the HIPAA Omnibus Rule.
Read more

OCR Delays Required Changes to Notices of Privacy Practices for Laboratories

September 20, 2013 | Blog

The HHS Office of Civil Rights (OCR) has granted certain clinical laboratories a temporary reprieve from the requirement to update their Notices of Privacy Practices (NPPs) by September 23, 2013, the deadline imposed by the HIPAA Omnibus Rule. 
Read more

Interagency Initiative Targets Consumer Fraud in the ACA Exchange Marketplace

September 19, 2013 | Blog | By Theresa Carnegie

Yesterday, the Attorney General, the Secretary of the Department of Health and Human Services (HHS), and the Chairwoman of the Federal Trade Commission (FTC) announced an interagency initiative to prevent consumer fraud and privacy violations in connection with the Affordable Care Act’s Health Insurance Marketplace.
Read more

OCR Publishes Model Notice of Privacy Practices

September 16, 2013 | Blog | By Kimberly Gold

With the September 23, 2013 compliance date for the HIPAA Omnibus Rule only one week away, the Office for Civil Rights (OCR) and the Office of the National Coordinator for Health Information Technology (ONC) have developed model Notices of Privacy Practices (“NPP”) to help health care providers and health plans ensure compliance.
Read more

Massachusetts Launches New Program to Combat Provider Fraud

September 12, 2013 | Blog | By Kimberly Gold

Last week, the Massachusetts’ Secretary of Health and Human Services, John Polanowicz, announced the launch of a new $5 million program designed to detect and prevent provider fraud, waste, and abuse in MassHealth, the Commonwealth’s Medicaid program.
Read more

OCR Guidance to Address HIPAA Marketing Turmoil

September 12, 2013 | Blog | By Theresa Carnegie

In response to a recent lawsuit and outcry from a variety of players in the health care market, the Department of Health and Human Services (“HHS”) has committed to issuing guidance by September 23rd (the compliance date for the Rule) on the drug refill provisions in the HIPAA Omnibus Rule (the “Rule”).
Read more

HIPAA Marketing Rules Prompt First Amendment Challenge

September 10, 2013 | Blog | By Theresa Carnegie

In what is believed to be the first legal challenge to the HIPAA Omnibus Rule (the “Rule”), a vendor of prescription drug adherence services is seeking an injunction to block certain provisions of the Rule related to drug refill reminders.
Read more

Serial Relator Getting the Boot?

September 5, 2013 | Blog | By Samantha Kingsbury

This past Friday, hospital company HCA Holdings, Inc. asked a federal court judge to dismiss a False Claims Act (FCA) suit filed by whistleblower and former employee, Stephen McMullen.
Read more

Fifth Circuit Joins Chorus to Rein in False Claims Act

August 27, 2013 | Blog | By Brian Dunphy

Add the Fifth Circuit to the list of jurisdictions questioning the use of the federal False Claims Act (FCA) in instances where - using the theory of implied certification - the alleged falsity is not apparent on the face of the claim. 
Read more

Government Prosecution in Qui Tam Cases Continues to Focus on Pharmaceutical Companies’ Sales and Marketing Activities

August 21, 2013 | Blog | By Theresa Carnegie

Qui tam actions filed against health care organizations unsealed in 2013 reveal that, although the government intervenes in less than 40% of qui tam actions, the government continues to aggressively prosecute multiple aspects of pharmaceutical companies’ sales and marketing activities.
Read more

Seven-Figure HIPAA Settlement Prompted by Photocopier Breach

August 15, 2013 | Blog | By Theresa Carnegie, Dianne Bourque

The Office for Civil Rights’ (OCR) latest seven-figure fine for HIPAA violations resulted from a failure to remove protected health information or “PHI” from the hard drive of a leased photocopier.
Read more

OIG and MA Plan Sponsor Settle Allegations of Altering Records Submitted During Audit

August 15, 2013 | Blog | By Roy Albert

Bravo Health Pennsylvania, Inc. (Bravo), a Medicare Advantage Plan Sponsor and subsidiary of Cigna Corporation, agreed to pay $225,000 to the Government for allegedly misrepresenting or falsifying information furnished to the OIG during an audit.  Bravo and the OIG entered into the settlement on July 26, 2013.
Read more

Does District Court Dismissal of Declined Qui Tam Threaten Future DOJ False Claims Enforcement?

August 8, 2013 | Blog | By Theresa Carnegie

The U. S. Department of Justice (DOJ) has taken the unusual step of appealing a federal district court’s dismissal of a declined qui tam brought under the federal and multiple state false claims acts (FCA).  Could the underlying opinion pose a threat to future DOJ health care enforcement efforts?
Read more

New Bill Proposes to Eliminate Stark Law Exception for Certain In-Office Ancillary Services

August 7, 2013 | Blog | By Karen Lovitch, Theresa Carnegie

Representative Jackie Speier (D-Calif) has introduced a bill (HR 2914) that would eliminate advanced diagnostic imaging, anatomic pathology, radiation therapy, and physical therapy services from the Stark Law’s in-office ancillary services exception (IOASE).
Read more

Subscribe

Sign up to receive email updates from Mintz.
Subscribe Now
Health Law Diagnosed Podcast Blog Button

Health Law Diagnosed: A Mintz Podcast

Telehealth Promo Button

Telehealth Updates

covid-19-compliance

Value-Based Care

Viewpoint Editors

Explore Other Viewpoints:

I'm Looking For...